Traynor Capital Management, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1666786
MALVERN, PA
Position in VRTX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$4,494,909
-$776,942 QoQ
Shares Held
9,049
-23.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#499
of 1,735 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $9,749,803 across 5 Biotechnology names. VRTX ranks #1 (46.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
9,049 | $4,494,909 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,458 | $3,148,171 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,005 | $1,873,737 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
19,200 | $168,096 | |
| 5 | NGEN |
Nervgen Pharma Corp.
|
31,500 | $64,890 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,494,909 | 9,049 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $5,271,851 | 11,806 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,334,687 | 11,767 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $4,685,972 | 11,965 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $5,197,710 | 11,675 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,354,352 | 11,044 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,320,357 | 5,762 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $235,330 | 506 | Shares | Sole | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||